How much profit has Gilead Sciences made this year?
Gilead Sciences has made 9.03 B USD this year.
In 2024, Gilead Sciences's profit amounted to 9.03 B USD, a 59.46% increase from the 5.67 B USD profit recorded in the previous year.
YEAR | NET INCOME (undefined USD) |
---|---|
2029e | 11.57 |
2028e | 11.15 |
2027e | 10.54 |
2026e | 9.9 |
2025e | 9.45 |
2024e | 9.03 |
2023 | 5.67 |
2022 | 4.59 |
2021 | 6.23 |
2020 | 0.12 |
2019 | 5.39 |
2018 | 5.46 |
2017 | 4.63 |
2016 | 13.5 |
2015 | 18.11 |
2014 | 12.1 |
2013 | 3.08 |
2012 | 2.59 |
2011 | 2.8 |
2010 | 2.9 |
2009 | 2.64 |
2008 | 1.98 |
2007 | 1.59 |
2006 | -1.19 |
2005 | 0.81 |
2004 | 0.45 |
In the annual report of the Gilead Sciences share (US3755581036, 885823, GILD), it breaks down its revenues into 1 segments: 1. innovative Medicines. The Gilead Sciences stock (WKN: 885823, ISIN: US3755581036, Ticker Symbol: GILD) is a leading investment for investors interested in participating in the Health Care sector.
The profit margins of Gilead Sciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Gilead Sciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Evaluating Gilead Sciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Gilead Sciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
When Gilead Sciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Gilead Sciences has made 9.03 B USD this year.
The profit has increased by 59.46% compared to last year increased
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
Gilead Sciences publishes its earnings in the form of quarterly or annual reports.
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
The profits of Gilead Sciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
You can learn more about the earnings of Gilead Sciences by reviewing the quarterly or annual reports or following the company presentations.
Over the past 12 months, Gilead Sciences paid a dividend of 3 USD . This corresponds to a dividend yield of about 4.53 %. For the coming 12 months, Gilead Sciences is expected to pay a dividend of 0.63 USD.
The current dividend yield of Gilead Sciences is 4.53 %.
Gilead Sciences pays a quarterly dividend. This is distributed in the months of July, October, January, April.
Gilead Sciences paid dividends every year for the past 15 years.
For the upcoming 12 months, dividends amounting to 0.63 USD are expected. This corresponds to a dividend yield of 0.95 %.
Gilead Sciences is assigned to the 'Health' sector.
To receive the latest dividend of Gilead Sciences from 3/28/2024 amounting to 0.77 USD, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
The last dividend was paid out on 3/28/2024.
In the year 2023, Gilead Sciences distributed 2.92 USD as dividends.
The dividends of Gilead Sciences are distributed in USD.
The Gilead Sciences stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Our stock analysis for Gilead Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gilead Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.